GRAL
GRAL clinical trials: GRAIL, Inc.
Every trial on ClinicalTrials.gov where GRAIL, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 8
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
GRAL on the catalyst calendar · GRAL registry changes
- Primary completion Sep 2030Sponsor estimateNo phase registeredNCT05673018Galleri® in the Medicare Population.GRAIL, Inc. · CancerRecruitingGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 12, 2026ActualNo phase registeredNCT05611632Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A...GRAIL, Inc. · CancerActive, not recruitingGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 11, 2026ActualNo phase registeredNCT05155605PATHFINDER 2: A Multi-Cancer Early Detection StudyGRAIL, Inc. · Early Detection of CancerActive, not recruitingGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2025ActualNo phase registeredNCT05205967REFLECTION: A Clinical Practice Learning Program for Galleri®GRAIL, Inc. · Early Detection of CancerActive, not recruitingGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2022ActualNo phase registeredNCT03085888The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer TypesGRAIL, Inc. · NeoplasmsCompletedGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2025Sponsor estimateNo phase registeredNCT06603259The Galleri® Community Research ProgramGRAIL, Inc. · Data CollectionUnknown statusGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2024Sponsor estimateNo phase registeredNCT02889978The Circulating Cell-free Genome Atlas StudyGRAIL, Inc. · NeoplasmsUnknown statusGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2021ActualNo phase registeredNCT04241796Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical PracticeGRAIL, Inc. · CancerCompletedGRALLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 12, 2025ActualNo phase registeredNCT03372902Development Of A Blood Test To Improve The Performance Of Breast Cancer ScreeningMemorial Sloan Kettering Cancer Center · Breast CancerCompletedGRALCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2025Sponsor estimateNo phase registeredNCT03934866The SUMMIT Study: A Cancer Screening StudyUniversity College, London · CancerActive, not recruitingGRALCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner